Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

India to demand faster USFDA inspections of pharma firms at Trade Policy Forum meet

Ruchika Sharma11 Jan 2024 1:30 PM IST

New Delhi: India will strongly demand fast-tracking American health regulator's USFDA inspections, or audit of domestic pharma firms, lifting...

Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USA

JnJ to acquire Ambrx Biopharma for USD 2 billion

Ruchika Sharma11 Jan 2024 12:30 PM IST

New Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Ambrx Biopharma, Inc., or Ambrx, a...

Lupin gets USFDA EIR for Pithampur Unit 3 facility

Lupin unveils smoking cessation tablets Varenicline in US

Ruchika Sharma11 Jan 2024 11:19 AM IST

It is indicated for use as an aid to smoking cessation treatment.

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck to acquire Harpoon Therapeutics for USD 680 million

Ruchika Sharma10 Jan 2024 4:31 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, and Harpoon Therapeutics, Inc. have announced that the companies have...

Novartis opens new radioligand therapy manufacturing facility in California

Novartis in advanced talks to buy Cytokinetics: Source

Ruchika Sharma10 Jan 2024 3:30 PM IST

Access to Cytokinetics products would help Novartis offset the expected loss of U.S. exclusivity of Entresto, its key drug in this field, said...

USFDA approves Medtronic Percept RC Deep Brain Stimulation system

Ruchika Sharma10 Jan 2024 2:30 PM IST

Dublin: Medtronic plc has announced the U.S. Food and Drug Administration (FDA) approval of its Percept RC Deep Brain Stimulation (DBS) system....

Sanofi names Brian Foard as head of Specialty Care Global Business Unit

Ruchika Sharma10 Jan 2024 1:30 PM IST

Paris: Brian Foard, a healthcare industry veteran and Sanofi leader in the U.S., has been named Head of the company's Specialty Care Global...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

Pfizer-Genmab Tivdak application accepted for priority review by USFDA for cervical cancer

Ruchika Sharma10 Jan 2024 12:30 PM IST

New York: Pfizer Inc. and Genmab A/S have announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental...

Lupin secures SBTi validation for emission reduction targets

Lupin unveils Bromfenac Ophthalmic Solution in US

Ruchika Sharma10 Jan 2024 11:28 AM IST

It is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.

Good Manufacturing Practices: Govt releases Schedule M guidelines, calls for stricter quality control, recall measures

Ruchika Sharma9 Jan 2024 2:30 PM IST

Some of the major changes which will happen with introduction of revised Schedule M to support upgradation of the units are introduction of...

Medicines for dialysis costing Rs 65 available for only Rs 5 in Jan Aushadhi Kendras: Amit Shah

Ruchika Sharma9 Jan 2024 1:30 PM IST

Generic medicines are available at 50-90 percent of market prices at these Kendras, ensuring affordable healthcare.

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

Aurobindo Pharma Telangana facility gets USFDA EIR

Ruchika Sharma9 Jan 2024 12:30 PM IST

Hyderabad: Aurobindo Pharma has announced that Unit VI-B, a Formulation manufacturing facility of the Company, situated at Chitkul Village,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok